CJ (001040) Q2 2026 earnings summary

Executive summary

• Revenue for Q2 2026 rose 3.7% year-over-year to ₩11.53 trillion, driven by growth in bio and overseas food sales, as well as expansion in Olive Young and logistics segments.

• Consolidated revenue for H1 2026 was KRW 22,979.3 billion, up 5.8% year-over-year, with operating income of KRW 992.4 billion and net income attributable to owners of the parent at KRW 137.1 billion.

• Operating profit declined 14.1% year-over-year to ₩531.8 billion due to increased costs from FX, oil prices, and higher SG&A for new business acceleration.

• Net profit dropped 57.2% year-over-year to ₩155.6 billion, impacted by lower operating profit and absence of prior year’s one-off gains.

• Major strategic moves included the sale of 14 subsidiaries in the Feed & Care segment, and ongoing investments in R&D and digital transformation.

Financial highlights

• Gross margin improved to 29.9% in Q2 2026 from 29.0% a year earlier.

• Revenue: KRW 22,979.3 billion for H1 2026, up from KRW 21,719.5 billion in H1 2025.

• Operating income: KRW 992.4 billion, down from KRW 1,149.7 billion in H1 2025.

• Net income attributable to owners: KRW 137.1 billion, compared to KRW 143.3 billion in H1 2025.

• SG&A expenses increased 12% year-over-year, reflecting investments in new businesses.

Outlook and guidance

• Global expansion in Olive Young and bakery businesses is expected to accelerate, with new B2B collaborations and product launches planned for the second half.

• The group is focusing on global expansion, digital transformation, and strengthening its core business segments.

• Ongoing marketing and product innovation initiatives aim to drive further growth in key segments.

• Continued investment in R&D, especially in food innovation, biotechnology, and digital platforms.

• Strategic divestitures and portfolio optimization are expected to improve profitability and focus.